Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Uncovering Root Causes Underlying Gaps in the Evaluation and Integration of the Latest Clinical Evidence in Congenital Thrombotic Thrombocytopenic Purpura: Key Findings from a National Hematology Care Team Survey

Azra Borogovac, Ellie Moses-Okwei, Lindsay Gurska, Emily Zyborowicz, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2024) 144 (Supplement 1): 3636.

https://doi.org/10.1182/blood-2024-203312

Published: 2024

Journal Articles

Advancing the Integration of CAR T-Cell Therapy in Community Oncology Centers: Key Findings from a Transformative Quality Improvement Initiative

M. Sarfraz Nawaz, Ellie Moses-Okwei, Lindsay Gurska, Emily Zyborowicz, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2024) 144 (Supplement 1): 7594.

https://doi.org/10.1182/blood-2024-203606

Published: 2024

Journal Articles

Collaborative Strategies to Enhance Treatment and Integration of Cellular Therapies in Multiple Myeloma: Results from Nationwide Multiple Myeloma Patient and Provider Surveys

M. Sarfraz Nawaz, Ellie Moses-Okwei, Lindsay Gurska, Emily Zyborowicz, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2024) 144 (Supplement 1): 5035.

https://doi.org/10.1182/blood-2024-203855

Published: 2024

Journal Articles

Advancing Patient-Centered Care to Overcome Health Disparities in Multiple Myeloma: Key Findings from a Quality Improvement Initiative

Joseph Mikhael, Cesar Rodriguez, Amy E. Pierre, M. Sarfraz Nawaz, Ellie Moses-Okwei, Lindsay Gurska, Emily Zyborowicz, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2024) 144 (Supplement 1): 5034.

https://doi.org/10.1182/blood-2024-203674

Published: 2024

Journal Articles

Differences in Treatment Decision-Making in Frontline Management of Lower-Risk Myelodysplastic Syndromes between Academic and Community Practice Settings: Results from a Nationwide Survey

Mikkael A. Sekeres, Sangeetha Venugopal, Namrata S. Chandhok, Justin M. Watts, Terrence Bradley, Justin Taylor, David Sallman, Zhuoer Xie, Eric Padron, Shelby Sullivan, Emily Zyborowicz, Jeffrey Carter, Cherilyn Heggen, Lindsay Gurska, Rami S. Komrokji

Blood (2024) 144 (Supplement 1): 3679.

https://doi.org/10.1182/blood-2024-203444

Published: 2024

Journal Articles

Accelerating the Adoption of New and Emerging Therapies for DLBCL: A Community-Based Quality Improvement Initiative

Peter A. Riedell, Ellie Moses-Okwei, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 7264.

https://doi.org/10.1182/blood-2023-173686

Published: 2023

Journal Articles

Optimizing the Integration of Genetic Testing in AML Care in Community Practice: Insights from a Quality Improvement Initiative

Catherine Lai, Adam Bagg, Lindsay Gurska, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 7277.

https://doi.org/10.1182/blood-2023-172976

Published: 2023

Journal Articles

Advancing Collaboration across the Multiple Myeloma Treatment Journey from Oncology Clinic to CAR T-Cell Center: A Paired Center Transformative Quality Improvement Initiative

Sikander Ailawadhi, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 5074.

https://doi.org/10.1182/blood-2023-173042

Published: 2023

Journal Articles

Advancing Care of Patients with Sickle Cell Disease through a Transformative Quality Improvement Initiative

Biree Andemariam, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 7224.

https://doi.org/10.1182/blood-2023-173457

Published: 2023

Journal Articles

Key Findings from a Transformative Quality Improvement Initiative on Advancing CAR T-Cell Treatment in Non-Hodgkin Lymphoma

Manali K. Kamdar, Ellie Moses-Okwei, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 3705.

https://doi.org/10.1182/blood-2023-173681

Published: 2023

Journal Articles

Optimizing Management of AML: Insights from a Community-Based Quality Improvement Initiative

Joshua F. Zeidner, Shelby Sullivan, Jeffrey Carter, Cherilyn Heggen

Blood (2023) 142 (Supplement 1): 7278.

https://doi.org/10.1182/blood-2023-173038

Published: 2023

NARROW

Uncovering Root Causes Underlying Gaps in the Evaluation and Integration of the Latest Clinical Evidence in Congenital Thrombotic Thrombocytopenic Purpura: Key Findings from a National Hematology Care Team Survey

Advancing the Integration of CAR T-Cell Therapy in Community Oncology Centers: Key Findings from a Transformative Quality Improvement Initiative

Collaborative Strategies to Enhance Treatment and Integration of Cellular Therapies in Multiple Myeloma: Results from Nationwide Multiple Myeloma Patient and Provider Surveys

Advancing Patient-Centered Care to Overcome Health Disparities in Multiple Myeloma: Key Findings from a Quality Improvement Initiative

Differences in Treatment Decision-Making in Frontline Management of Lower-Risk Myelodysplastic Syndromes between Academic and Community Practice Settings: Results from a Nationwide Survey

Accelerating the Adoption of New and Emerging Therapies for DLBCL: A Community-Based Quality Improvement Initiative

Optimizing the Integration of Genetic Testing in AML Care in Community Practice: Insights from a Quality Improvement Initiative

Advancing Collaboration across the Multiple Myeloma Treatment Journey from Oncology Clinic to CAR T-Cell Center: A Paired Center Transformative Quality Improvement Initiative

Advancing Care of Patients with Sickle Cell Disease through a Transformative Quality Improvement Initiative

Key Findings from a Transformative Quality Improvement Initiative on Advancing CAR T-Cell Treatment in Non-Hodgkin Lymphoma

Optimizing Management of AML: Insights from a Community-Based Quality Improvement Initiative

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only